ISRCTN14523624已完成不适用
Is beta-lactam therapy, until the patient has been afebrile for 48 hours (at least 5 days), sufficient for the treatment of community-acquired pneumonia?
The Research Committee of Orebro County Council (Sweden)0 个研究点目标入组 200 人开始时间: 2006年2月7日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Adult patients with uncomplicated febrile community-acquired pneumonia, with chest X-ray infiltrates, who initially experience improvement with beta-lactam monotherapy
排除标准
- •Nursing home resident, hospitalisation during the preceding month, antibiotic treatment for any reason during the preceding week, ongoing antipyretic medication. Inability to make a telephone conversation or to attend to a follow-up visit
研究者
相似试验
进行中（未招募）
1 期
Pilot study: pharmacokinetics of beta-lactam antibiotics, piperacillin-tazobactam, ceftazidim and meropenem in blood and sputum of cystic fibrosis patients.Cystic fibrosisEUCTR2016-000398-19-BEGhent University45
尚未招募
不适用
Continuous vs. intermittent beta-lactam dosing in critically ill patients with sepsis: A randomized controlled trial.SepsisPACTR202009811610400Applied for and awaiting approval408
已完成
不适用
Prolonged versus Intermittent beta-lactam Antibiotics Intravenous Infusion Strategy in Sepsis or Septic Shock: A Systematic Review and Meta-Analysis of Randomized Trials.Sepsis or septic shockJPRN-UMIN000040688Juntendo University Urayasu Hospital825
招募中
4 期
Continuous infusion antipseudomonalbeta-lactams for acute infective exacerbations in cystic fibrosis: a prospective randomised controlled trialAcute pulmonary exacerbation of cystic fibrosisInfection - Studies of infection and infectious agentsRespiratory - Other respiratory disorders / diseasesHuman Genetics and Inherited Disorders - Cystic fibrosisACTRN12612000945820Dr Anton Peleg120
招募中
不适用
Does guideline-based dosing of beta lactam antibiotics and vancomycin achieve the target drug concentrations more than therapeutic drug monitoring-based dosing in critically ill patients? (GUIDE TRIAL)SepsisACTRN12619000693123Paul Williams150